Nabriva Therapeutics plc Research and Development in Process
Nabriva Therapeutics plc reported Research and Development in Process of $32.05 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2021-03-11
- Nabriva Therapeutics plc research and development in process for the quarter ending 2018-12-31 was $118.00K.
- Nabriva Therapeutics plc research and development in process for fiscal 2018 was $32.05M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|
| 2018-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $32.05M 10-K · filed 2021-03-11 | |
| 2018-09-30 | $31.93M 10-Q · filed 2019-11-12 |